Viewing Study NCT06450106

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 4:03 PM
Ignite Modification Date: 2026-03-11 @ 1:02 AM
Study NCT ID: NCT06450106
Status: RECRUITING
Last Update Posted: 2025-06-27
First Post: 2024-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
Sponsor: SURGE Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Intraoperative View
None Dose escalation View
None Open-label View
None STM-416 View
None Resiquimod View
None Toll-like receptor 7/8 View
None Radical prostatectomy View
None Robotic prostatectomy View
None Immunotherapy View
None STM-416p View
None PSA View
None R848 View
None Hydrogel View